Pure Global

Efficacy of Noisome as A Carrier of Locally Delivered Minocycline Hydrochloride Gel - Trial NCT06255067

Access comprehensive clinical trial information for NCT06255067 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Ain Shams University and is currently Not yet recruiting. The study focuses on Periodontitis. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06255067
Phase 2/3
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov โ€ข NCT06255067
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy of Noisome as A Carrier of Locally Delivered Minocycline Hydrochloride Gel
Efficacy of Noisome as A Carrier of Locally Delivered Minocycline Hydrochloride Gel in Stage II or Stage III Periodontitis: A Randomized Controlled Clinical Trial With Biochemical Analysis

Study Focus

Periodontitis

Minocycline hydrochloride with noisome carrier

Interventional

drug

Sponsor & Location

Ain Shams University

Cairo,Cairo, Egypt

Timeline & Enrollment

Phase 2/3

Feb 25, 2024

Jun 30, 2024

30 participants

Primary Outcome

To measure clinical assessment Plaque Index (PI) in both groups (mincycline hydrochloride with noisome as carrier & minocycline hydrochloride only),To measure clinical assessment Gingival Index (GI) in both groups (mincycline hydrochloride with noisome as carrier & minocycline hydrochloride only),To measure Clinical attachment level (CAL) in both groups (mincycline hydrochloride with noisome as carrier & minocycline hydrochloride only),To measure Periodontal Pocket Depth (PPD) in both groups (mincycline hydrochloride with noisome as carrier & minocycline hydrochloride only)

Summary

The goal of this clinical trial is to compare the efficacy of Noisome as carrier of
 minocycline hydrochloride gel to minocycline hydrochloride in Stage II or Stage III
 Periodontitis . The main questions it aims to answer are:
 
 - Is the Noisome carrier of minocycline hydrochloride has an effect in comparing to
 minocycline hydrochloride in Stage II or Stage III Periodontitis?
 
 - what is the release profile of of minocycline hydrochloride noisome gel and minocycline
 hydrochloride gel? Participants will be asked to maintain oral hygiene after application
 of treatment Researchers will compare the effect of noisome as a carrier of locally
 delivered minocycline hydrochloride gel to minocycline hydrochloride gel in stage II or
 stage III periodontitis patients as an adjunct to non-surgical periodontal treatment] to
 see if Plaque Index (PI) , Gingival index,Clinical attachment level (CAL) &Periodontal
 Pocket Depth decreased or not.

ICD-10 Classifications

Chronic periodontitis
Periodontosis
Acute periodontitis
Chronic apical periodontitis
Periodontal disease, unspecified

Data Source

ClinicalTrials.gov

NCT06255067

Non-Device Trial